NEUROMYELITIS OPTICA

Clinical trials for NEUROMYELITIS OPTICA explained in plain language.

Never miss a new study

Get alerted when new NEUROMYELITIS OPTICA trials appear

Sign up with your email to follow new studies for NEUROMYELITIS OPTICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 3 Completed 1 Terminated 1

New combo therapy aims to tame rare brain disease with fewer steroids

Disease control Not yet recruiting

This study tests a new drug called inectolizumab combined with steroids in people newly diagnosed with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the nerves. The goal is to see if the drug can help control the disease while allowing pat…

Matched conditions: NEUROMYELITIS OPTICA

Phase: NA • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control

Last updated May 13, 2026 16:03 UTC

NEUROMYELITIS OPTICA

Get alerted when new NEUROMYELITIS OPTICA trials appear

New combo therapy aims to tame rare brain disease with fewer steroids